KGMA demonstrates Ingen's Oxyview product line to military medical professionals

NewsGuard 100/100 Score

Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative proprietary solutions for the $8 billion respiratory market, today announced that its partner, KGMA, successfully demonstrated its product at the 13th Annual Force Health Protection Conference in Phoenix, Arizona.

Approximately 2,200 individuals attended the conference, where KGMA made numerous presentations of Ingen's Oxyview product line to military doctors, nurses and other military medical professionals. The product was very well received and the medical personnel present could readily comprehend the value and benefits that the technology provided for both patients and medical device providers.

Contact and ordering information was provided to a large number of military representatives who expressed interest in Ingens' products, including U.S. Army institutions in Georgia, Washington D.C., Michigan, New Mexico, Hawaii and others. Additionally, KGMA received inquiries related to Ingen's listing on the GSA schedule, which also shows positive signs of interest.

"Ingen continues to rapidly scale its sales efforts across a number of markets, while offering top-quality products to America's Armed Forces," said CEO Scott Sand. "Oxyview Flow Meters greatly improve quality-of-care at an unbeatable value, as we continue to target $1.4 million in revenue available through various government facilities for the remainder of the year."

Source : Ingen Technologies

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Antibiotics ineffective for cough treatment in lower respiratory tract infections